Definition

Antidepressants are a class of medications that are used primarily in the treatment of clinically severe mood or anxiety disorders. The majority of effective antidepressants currently in use enhance neurotransmission of serotonin and/or norepinephrine. Generally, this is achieved by blocking the reuptake of the neurotransmitter substance(s), inhibiting the enzymes responsible for its metabolism, or directly stimulating the postsynaptic receptors (Iversen, Iversen, Bloom, & Roth, 2009). Several antidepressants are also used in treating generalized anxiety disorder, panic disorder, and obsessive–compulsive disorder (Bourin & Lambert, 2002). Other conditions for which antidepressants have demonstrated efficacy include eating disorders (Powers & Bruty, 2009), neuropathic pain (O’Connor & Dworkin, 2009), stress incontinence, nocturnal eneuresis, ejaculatory disorders (Michel, Ruhe, de Groot, Castro, & Oelke, 2006), migraine headaches, fibromyalgia (Stone, Viera, & Parman, 2003),...

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 1,350.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 1,299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free ship** worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References and Readings

  • Bourin, M., & Lambert, O. (2002). Pharmacotherapy of anxious disorders. Human Psychopharmacology: Clinical Experimental, 17, 383–400.

    Google Scholar 

  • Chung, B., Suzuki, A. R., & McGough, J. J. (2002). New drugs for treatment of attention-deficit/hyperactivity disorder. Expert Opinion Emerging Drugs, 7, 269–276.

    Google Scholar 

  • FDA Press Release. Extracted from http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2007/ucm108905.htm on 1/21/2010

  • Fournier, J. C., DeRubeis, R. J., Hollon, S. D., Dimidjian, S., Amsterdam, J. D., Shelton, R. C., et al. (2010). Antidepressant drug effects and depression severity: A patient-level meta-analysis. JAMA, 303, 47–53.

    PubMed Central  PubMed  Google Scholar 

  • Grant, J. E., & Grosz, R. (2004). Pharmacotherapy outcome in older pathological gamblers: A preliminary investigation. Journal of Geriatric Psychiatry and Neurology, 17, 9–12.

    PubMed  Google Scholar 

  • Hammad, T. A., Laughren, T., & Racoosin, J. (2006). Suicidality in pediatric patients treated with antidepressant drugs. Archives of General Psychiatry, 63, 332–339.

    PubMed  Google Scholar 

  • Horstmann, S., & Binder, E. B. (2009). Pharmacogenomics of antidepressant drugs. Pharmacology and Therapeutics, 124, 57–73.

    PubMed  Google Scholar 

  • Iversen, L. L., Iversen, S. D., Bloom, F. E., & Roth, R. H. (2009). Antidepressants and Anxiolytics. Introduction to Neuropsychopharmacology (pp. 306–335). New York: Oxford University Press.

    Google Scholar 

  • Kirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., Johnson, B. T. (2008). Initial severity and antidepressant benefits: A meta-analysis of data submitted to the food and Drug Administration. PlOS Medicine, 5, e45.

    PubMed Central  PubMed  Google Scholar 

  • Michel, M. C., Ruhe, H. G., de Groot, A. A., Castro, R., & Oelke, M. (2006). Tolerability of amine uptake inhibitors in urologic diseases. Current Drug Safety, 1, 73–85.

    PubMed  Google Scholar 

  • O’Connor, A. B., & Dworkin, R. H. (2009). Treatment of neuropathic pain: An overview of recent guidelines. American Journal of Medicine, 122(Suppl. 10), S22–32.

    PubMed  Google Scholar 

  • Powers, P. S., & Bruty, H. (2009). Pharmacotherapy for eating disorders and obesity. Child Adolescent Psychiatric Clinics of North America, 18, 175–187.

    PubMed  Google Scholar 

  • Rihmer, Z., & Akiskal, H. (2006). Do antidepressants t(h)reat(en) depressives? Toward a clinical judicious formulation of the antidepressant-suicidality FDA advisory in light of declining national suicide statistics from many countries. Journal of Affective Disorders, 94, 3–13.

    PubMed  Google Scholar 

  • Skolnick, P., Popik, P., & Trullas, R. (2009). Glutamate-based antidepressants: 20 years on. Trends in Pharmacological Sciences, 30, 563–569.

    PubMed  Google Scholar 

  • Stone, K. J., Viera, A. J., & Parman, C. L. (2003). Off-label applications for SSRIs. American Family Physician, 68, 498–504.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this entry

Cite this entry

Tschanz, J.T., Treiber, K. (2011). Antidepressants. In: Kreutzer, J.S., DeLuca, J., Caplan, B. (eds) Encyclopedia of Clinical Neuropsychology. Springer, New York, NY. https://doi.org/10.1007/978-0-387-79948-3_1771

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-79948-3_1771

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-0-387-79947-6

  • Online ISBN: 978-0-387-79948-3

  • eBook Packages: Behavioral Science

Publish with us

Policies and ethics

Navigation